GlaxoSmithKline Pharmaceuticals · NSE: GLAXO · BSE: 500660
Q1 FY19 results · Apr–Jun 2018
GlaxoSmithKline Pharmaceuticals reported revenue from operations of ₹735.65 crore and net profit of ₹88.59 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 735.65 | — | — | — | — |
| Other income | 17.78 | — | — | — | — |
| Total income | 753.43 | — | — | — | — |
| Profit before tax | 138.31 | — | — | — | — |
| Net profit for the period | 88.59 | — | — | — | — |
| EPS, basic (₹) | 10.46 | — | — | — | — |
| Net margin (%) | 12.0 | — | — |
Standalone
- Filed with BSE
- 25 Jul 2018, 12:01 IST
- Board meeting
- 24 Jul 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE